IAH Announcement, page-13

Ah Playez how about some prime swamp land.

The good Dr. Hawley has background in e-commerce, data analytics, and social media. Essentially this background is being harnessed by IAH to spam the POH threads on HC.

Posters have been reduced to re-tweaters while blissfully ignorant of their role in the process. It’s the dumbing down of life.

Meanwhile POH circles the drain.

POH need to update the market about what occurred in the FDA pre-IND meeting for the oxym systemic P2 trial in the US. They announced in November 2014 that this was the next step. Has it even happened?

At 3c a share you don’t need to be Sherlock Holmes to work out that without the carrot of the oxym patch the market value of POH is significantly less than even where it is today.

Therein lies the problem. And POH is a dead duck walking until the new CEO breaks his silence about what hes discovered when he pulled up a few floorboards to look at what lies under the POH house of horrors.

Maybe someone should tweet: “Wot new on pain ptch thx”